Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF...
7 insider purchases on record · latest filing 2026-02-26.
Insiders have also filed 4 sale transactions at ZURA.